SNY:NASDAQ, Sanofi
SNY stock overview
Sanofi (SNY:NASDAQ) closed at $48.46 on November 13, 2026,
down 0.01% on the day.
The stock trades 8.0% below its 52-week high of $52.67
and 24.0% above its 52-week low of $39.07.
Over the past year, it lost 7.4%.
Sanofi is part of the Health Care sector (Major Pharmaceuticals).
Key figures
- Price
- $48.46
- Day change
- -0.01%
- Volume
- 383,539
- Average volume
- 3,361,362
- Market cap
- 116B+
- 52-week range
- $39.07 – $52.67
- 50-day average
- $42.60
- 200-day average
- $44.35
Price action over the past year
In 252 trading sessions since November 12, 2025, SNY closed higher on 131 days (52%).
Its best day was June 4, 2026 (+4.74%) and its worst was May 4, 2026 (-5.92%).
It never moved 10% or more in a single session.
Recent signals
SNY news
-
Nov 13, 2026:
Why Is Sanofi (ENXTPA:SAN) Expanding Its R And D Bets In Vaccines And Gene Editing?
-
Nov 13, 2026:
Windward prices $175M IPO to advance China-licensed lung drugs
-
Nov 12, 2026:
Scribe Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
-
Nov 12, 2026:
Sanofi: Information concerning the total number of voting rights and shares - October 2026
-
Nov 12, 2026:
The world's most sophisticated drug companies are putting billions into vaccines - despite the political environment
-
Nov 12, 2026:
Biomatter Raises $18M Series A to Scale Its AI-Powered Enzyme Design for Global Industry Leaders
-
Nov 11, 2026:
Recursion Pharmaceuticals Inc (RXRX) Q3 2026 Earnings Call Highlights: Durable FAP Data, Early ...
-
Nov 10, 2026:
Sanofi (SNY) Is Planning for a Patent Loss, Here's Where Bulls Still See Opportunity
About Sanofi
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. The company offers a diverse array of drugs with its highest revenue generator, Lantus, representing just over 10% of total sales. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of sales.
Similar stocks
Find more stocks like SNY with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.